For sermorelin acetate storage and stability, keep the dry cake sealed, frozen and dark, and keep any solution refrigerated. Its length means it can clump together, a risk that chemistry tests do not see. The acetate salt also pulls water from the air, so moisture is the fault that undoes everything else.
- Sealed and frozen as lyophilized cake, refrigerated in solution, dark in both states.
- At 29 residues the peptide can aggregate, a physical change chemistry tests do not see.
- Freeze-thaw cycling concentrates solutes locally as ice forms, which drives aggregation.
- The acetate salt is hygroscopic, more so than the trifluoroacetate form before exchange.
- A collapsed or slumped cake is the visible sign of moisture ingress.
- The methionine oxidises to a form 16 mass units heavier, harder to spot on a large molecule.
How should sermorelin be stored?
Sealed and dry, a bag of brown sugar stays loose; left open to damp air, it pulls in water and clumps. Imagine the powder in this vial behaving the same way: it stays good only while it is sealed and dry.
Sealed and frozen as lyophilized cake, refrigerated once a solution exists, dark in both states, and kept away from humid air whenever the vial is open.
The dry form is the stable one. Freeze-drying removes the water that hydrolysis needs, and a sealed vial below freezing in the dark is the condition every retest date assumes.
Refrigeration rather than freezing works for a vial in regular use, trading a little stability for fewer temperature cycles. For a peptide this long that trade is worth making, because the cycles themselves carry a risk that shorter peptides largely escape.
- Sealed and frozen as lyophilized cake, in the dark
- Refrigerated once a solution exists
- Avoid freeze-thaw: each freeze concentrates the peptide locally
- Do not shake, because interfaces are where unfolding starts
- The acetate salt draws moisture; open the vial at room temperature
- A collapsed cake or a hazy solution ends the vial
Why does length change the storage problem?
Because a long chain can fold, and folding creates a failure mode chemistry alone does not describe. Sermorelin is 29 residues, long enough to adopt structure and long enough for two molecules to associate with each other.
That association is aggregation. It is a physical change rather than a chemical one: no bond is broken and no atom is added, so the molecular mass of each individual molecule is unchanged.
Which means an identity test can pass on aggregated material. A mass spectrometer reports the monomer it was given, and a reversed-phase separation may show a normal peak. Aggregation is real, it matters, and the routine analytical panel is close to blind to it.
What actually triggers aggregation?
Concentration, agitation, temperature swings and interfaces. A concentrated solution has more opportunity for molecules to meet than a dilute one. Vigorous shaking drives molecules to the air-liquid interface, which is where unfolding tends to begin.
Freeze-thaw cycling is the one most people underestimate. Each freeze concentrates the solutes as ice forms, briefly pushing the peptide to a much higher local concentration than the label suggests.
The practical rules follow directly and none of them are fussy. Avoid repeated freeze-thaw, do not shake, and do not leave a solution warm for longer than the work needs.
Does the methionine matter here too?
Yes, and it is worth knowing which residue the sulfur in C149H246N44O42S belongs to. Sermorelin carries a methionine, and methionine is the most readily oxidised of the common amino acids.
The oxidised form weighs 16 mass units more and is a different molecule. On a 3,358-dalton peptide that shift is proportionally small, so it is harder to see than the same shift on a short peptide and it is no less real.
The storage response is the same as for any oxidation-prone peptide: dark, sealed, cold, and fewer entries rather than more. What differs is that here it competes for attention with aggregation, and both deserve it.
Why is the acetate salt hygroscopic?
Acetate salts of peptides draw moisture from the air readily, more so than the trifluoroacetate form the material starts as before ion exchange. That is a property of the finished product rather than a defect in it.
The consequence is that an opened vial in a humid room takes on water faster than intuition suggests. Water is what freeze-drying removed, and putting it back undoes the reason the material was freeze-dried.
It also quietly moves the numbers. A vial that has absorbed moisture weighs more per unit of peptide than it did at test, so the net peptide content figure on the certificate becomes slightly generous without anything being wrong with the certificate.
What does a retest date actually mean?
It describes an unopened container held under the conditions printed beside it, derived from stability data: units stored at defined temperature and humidity, pulled on a schedule, tested against the release specification.
The date is conditional on those conditions. A vial that spent a week on a warm bench is no longer described by it, and nothing about the vial looks different.
It is also not a cliff. Material past a retest date is not established as failing, it is outside the evidence, and the honest response is to test rather than assume in either direction. A pharmaceutical expiry is a stronger claim made under rules research-grade material is not made under.
What happens once the vial is opened?
Two clocks start. Moisture is the first: lyophilized cake is hygroscopic and the acetate form more so, and opening a cold vial in a warm room pulls condensation directly onto it. Letting the vial reach room temperature before opening costs nothing and removes the problem.
Air is the second. Every entry exchanges some headspace, and headspace air carries oxygen, which matters for a peptide carrying a methionine.
Cake collapse is the visible consequence when moisture wins. A lyophilized cake that has slumped, shrunk from the vial wall, or turned glassy has taken on water, and that is a signal worth acting on rather than working around.
Does the container matter as much as the temperature?
Close to it. The vial and its closure are part of the product rather than packaging, and the storage claim depends on both holding.
A stopper pierced repeatedly, or pierced with a blunt needle, may not reseal cleanly. That admits air and humid room air into a vial whose entire rationale is that neither gets in, and the cake looks unchanged for a while afterwards.
Light transmission matters because of the methionine. Amber glass solves it and so does the original carton, and the carton is free.
What does stability testing not capture?
Everything after dispatch. A stability study tests unopened units under controlled conditions, so its results describe an ideal a working vial stops matching at first entry.
Transit is the least documented stretch of the timeline. A parcel can sit in a hot vehicle for a day or freeze overnight and none of it appears on any paperwork. For a dry cake the chemical risk from that is modest; the mechanical risk to the closure is not.
Aggregation is the other gap, and a specific one for this compound. It develops in storage and in solution, and a certificate written at release describes material that had not yet had the opportunity to do it.
What should make you stop using a vial?
A cake that has collapsed, slumped, or pulled away from the glass. That is moisture, and it is the most useful signal this format gives without equipment.
In solution, cloudiness, haze or visible particulate. For a long peptide those can be the visible end of aggregation, which is exactly the failure the analytical panel does not report.
A closure that has lifted, cracked or no longer sits flush counts even when the contents look fine. None of these require equipment, and they catch what a certificate cannot, because a certificate describes the vial as it was filled.
How does storage relate to the certificate?
They split the timeline and neither covers the other half. A certificate reports what was measured on a sample drawn at one moment, and the certificate guide covers how to read one field by field. Storage evidence covers what happened afterwards.
The split has a sharp edge for this compound. Aggregated material can still pass an identity test and can still show a reasonable purity figure, so a clean certificate does not rule out a physical problem that developed later.
Lot reports for material supplied here resolve through the certificate verification page, and the sizes carried are on the sermorelin acetate product record.
What is the regulatory position?
Stability expectations for finished pharmaceutical products are set out in international guidance defining storage conditions, sampling intervals and the testing behind a shelf-life claim. That framework governs drug products made for human use.
Sermorelin has existed as an approved drug substance in such a product. Research-grade material is not that product, and its documentation does not carry pharmacopeial weight. A supplier can honestly report the conditions a lot was held under and what was measured; presenting that as a drug product shelf life would overstate it.
The useful question stays narrow: what conditions, what measurement, what date.
FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR PERSONAL, MEDICAL, DIAGNOSTIC, THERAPEUTIC, OR RECREATIONAL USE.
What is Sermorelin Acetate studied for?
Published research on Sermorelin Acetate investigates the areas below, which is a different question from what Sermorelin Acetate will do for anyone, a claim about a living system that nothing on this site is sold for.
What it is. A man-made peptide matching the first 29 building blocks of growth-hormone-releasing hormone.
What the research looks at. An older clinical and hormone-research record exists, mostly about how the GHRH receptor behaves and about using the peptide as a diagnostic tool.
How it is thought to work. It works on the GHRH receptor. Those first 29 building blocks are the shortest piece of the natural hormone that still works on the receptor, which is why the class is built on that particular cut.
What is not established. What is sold here is a research chemical, not a drug product. Sermorelin, CJC-1295 and Mod GRF(1-29) are close relatives and get mixed up constantly in commercial listings, so check the certificate for which molecule is actually in the vial.
The full record, including the certificate for the lot in stock, is on the Sermorelin Acetate product page.
Common questions
Does sermorelin need to be frozen?
What is aggregation, and would a certificate show it?
Why is the acetate salt more hygroscopic?
What does a collapsed lyophilized cake mean?
Does sermorelin oxidise?
More documentation guides
Sources
- PubChem Compound Summary for CID 16132413, Sermorelin. The openable record for the free peptide, giving the 29-residue composition and the sulfur-containing methionine referred to in the oxidation discussion above.
- ICH Q2(R2), Validation of Analytical Procedures . Defines what makes an analytical result valid and reproducible, and is the basis for treating a stability figure without a named method and stated conditions as unverifiable.
- FDA guidance, Q6B Specifications: Test Procedures and Acceptance Criteria. Sets out why physical attributes such as aggregation are specified and tested separately from identity and chemical purity, which is the gap described above.
